Let’s work together to raise awareness, support research, and drive innovation to improve outcomes for all children battling cancer – Genomate Health

Genomate Health made the following post on LinkedIn:

“It’s Childhood Cancer Awareness Month!

This month, we stand with the brave children and families facing the challenges of childhood cancer. Every year, thousands of children are diagnosed with cancer, and their journeys are filled with courage, resilience, and hope.

At Genomate Health, we’re committed to advancing precision oncology to bring more personalized, effective treatments to young patients. Our study, published in the World Journal of Pediatrics, showcases the real-world impact of our technology. Genomate identified actionable targeted treatment options for 72% of pediatric cancer patients, with the molecular tumor board approving these therapies in 78% of cases—rising to 88% by 2020, thanks to continuous updates in our evidence database.

Read the full study.

Let’s work together to raise awareness, support research, and drive innovation to improve outcomes for all children battling cancer.”

Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors

Authors: Barbara Vodicska, Júlia Déri, Dóra Tihanyi, Edit Várkondi, Enikő Kispéter, Róbert Dóczi, Dóra Lakatos, Anna Dirner, Mátyás Vidermann, Péter Filotás, Réka Szalkai-Dénes, István Szegedi, Katalin Bartyik, Krisztina Míta Gábor, Réka Simon, Péter Hauser, György Péter, Csongor Kiss, Miklós Garami & István Peták

Source: Genomate Health/LinkedIn